References
- Allende JE, Allende CC. Protein kinases. 4. Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation. FASEB Journal. 1995. 9: 313-323. https://doi.org/10.1096/fasebj.9.5.7896000
- Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, Rhee SG. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. Journal of Biological Chemistry. 1997. 272: 217-221. https://doi.org/10.1074/jbc.272.1.217
- Brennan JP, Bardswell SC, Burgoyne JR, Fuller W, Schroder E, Wait R, Begum S, Kentish JC, Eaton P. Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation. Journal of Biological Chemistry. 2006. 281: 21827-21836. https://doi.org/10.1074/jbc.M603952200
- Burness ML, Grushko TA, Olopade OI. Epidermal growth factor receptor in triplenegative and basal-like breast cancer: promising clinical target or only a marker? Cancer Journal. 2010. 16: 23-32. https://doi.org/10.1097/PPO.0b013e3181d24fc1
- Carew JS, Huang P. Mitochondrial defects in cancer. Molecular Cancer. 2002. 1: 15.
- Chua MM, Ortega CE, Sheikh A, Lee M, Abdul-Rassoul H, Hartshorn KL, Dominguez I. CK2 in Cancer: Cellular and biochemical mechanisms and potential therapeutic target. Pharmaceuticals (Basel). 2017. 10: 30. https://doi.org/10.3390/ph10010030
- Clemons M, Goss P. Estrogen and the risk of breast cancer. New England Journal of Medicine. 2001. 344: 276-285. https://doi.org/10.1056/NEJM200101253440407
- Duncan JS, Litchfield DW. Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochimica et Biophysica Acta. 2008. 1784: 33-47. https://doi.org/10.1016/j.bbapap.2007.08.017
- Felty Q. Singh, KP, Roy D. Estrogen-induced G1/S transition of G0-arrested estrogen-dependent breast cancer cells is regulated by mitochondrial oxidant signaling. Oncogene. 2005. 24: 4883-4893. https://doi.org/10.1038/sj.onc.1208667
- Felty Q, Xiong WC, Sun D, Sarkar S, Singh KP, Parkash J, Roy D. Estrogen induced mitochondrial reactive oxygen species as signal-transducing messengers, Biochemistry. 2005. 44: 6900-6909. https://doi.org/10.1021/bi047629p
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer. 2010. 127: 2893-2917. https://doi.org/10.1002/ijc.25516
-
Filhol O, Giacosa S, Wallez Y, Cochet C. Protein kinase CK2 in breast cancer: the
$CK2{\beta}$ regulatory subunit takes center stage in epithelial plasticity. Cellular and Molecular Life Sciences. 2015. 72: 3305-3322. https://doi.org/10.1007/s00018-015-1929-8 - Fujino G, Noguchi T, Matsuzawa A, Yamauchi S, Saitoh M, Takeda K, Ichijo H. Thioredoxin and TRAF Family Proteins Regulate Reactive Oxygen Species-Dependent Activation of ASK1 through Reciprocal Modulation of the N Terminal Homophilic Interaction of ASK1. Molecular and Cellular Biology. 2007. 27: 8152-8163. https://doi.org/10.1128/MCB.00227-07
- Giorgi C, Agnoletto C, Baldini C, Bononi A, Bonora M, Marchi S, Missiroli S, Patergnani S, Poletti F, Rimessi A, Zavan B, Pinton P. Redox control of protein kinase C: Cell-and disease-specific aspects. Antioxidants & Redox Signaling. 2010. 13: 1051-1085. https://doi.org/10.1089/ars.2009.2825
-
Giusiano S, Cochet C, Filhol O, Duchemin-Pelletier E, Secq V, Bonnier P, Carcopino X, Boubli L, Birnbaum D, Garcia S, Iovanna J, Charpin C. Protein kinase
$CK2{\alpha}$ subunit overexpression correlates with metastatic risk in breast carcinomas: quantitative immunohistochemistry in tissue microarrays. European Journal of Cancer. 2011. 47: 792-801. https://doi.org/10.1016/j.ejca.2010.11.028 - Groenen LC, Nice E, Burgess AW. Structure-function relationships for the EGF/TGF-alpha family of mitogens. Growth Factors. 1994. 11: 235-257. https://doi.org/10.3109/08977199409010997
- Hofmann F, Feil R, Kleppisch T, Schlossmann J. Function of cGMP Dependent Protein Kinases as Revealed by Gene Deletion. Physiological Review. 2006. 86: 1-23. https://doi.org/10.1152/physrev.00015.2005
-
Kim KJ, Cho KD, Jang KY, Kim HA, Kim HK, Lee HK, Im SY. Platelet-activating factor enhances tumor metastasis via the reactive oxygen species-dependent protein kinase casein kinase 2-mediated nuclear factor-
${\kappa}B$ activation. Immunology. 2014. 143: 21-32. https://doi.org/10.1111/imm.12283 - Lemke G. Neuregulins in development. Molecular and Cellular Neuroscience. 1996. 7: 247-262. https://doi.org/10.1006/mcne.1996.0019
-
Li Z, Zhang G, Feil R, Han J, Du X. Sequential activation of p38 and ERK pathways by cGMP-dependent protein kinase leading to activation of the platelet integrin
${\alpha}IIb{\beta}3$ . Blood. 2006. 107: 965-972. https://doi.org/10.1182/blood-2005-03-1308 - Litchfield DW. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochemical Journal. 2003. 369: 1-15. https://doi.org/10.1042/bj20021469
- Mahadev K, Zilbering A, Zhu L, Goldstein BJ. Insulin-stimulated hydrogen peroxide reversibly inhibits protein-tyrosine phosphatase 1b in vivo and enhances the early insulin action cascade. Journal of Biological Chemistry. 2001. 276: 21938-21942. https://doi.org/10.1074/jbc.C100109200
- Me'nard S, Pupa SM, Campiglio M, Tagliabue E. Biologic and therapeutic role of HER2 in cancer. Oncogene. 2003. 22: 6570-6578. https://doi.org/10.1038/sj.onc.1206779
- Mendelsohn J, Baselga J. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. Journal of Clinical Oncology. 2003. 21: 2787-2799. https://doi.org/10.1200/JCO.2003.01.504
- Ohba M, Shibanuma M, Kuroki T, Nose K. Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells. Journal of Cell Biology. 1994. 126: 1079-1088. https://doi.org/10.1083/jcb.126.4.1079
- Okoh V, Deoraj A, Roy D. Estrogen-induced reactive oxygen species-mediated signalings contribute to breast cancer. Biochim Biophys Acta. 2011. 1815: 115-133.
- Parkash J, Felty Q, Roy D. Estrogen exerts a spatial and temporal influence on reactive oxygen species generation that precedes calcium uptake in high-capacity mitochondria: implications for rapid nongenomic signaling of cell growth. Biochemistry. 2006. 45: 2872-2881. https://doi.org/10.1021/bi051855x
- Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jefrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lonning PE, Borresen-Dale AL, Brown PO, Botstein D. Molecular portraits of human breast tumours. Nature. 2000. 406: 747-752. https://doi.org/10.1038/35021093
- Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Prognostic markers in triple-negative breast cancer. Cancer. 2007. 109: 25-32. https://doi.org/10.1002/cncr.22381
- Roy D, Cai Q, Felty Q, Narayan S. Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. Journal of Toxicology and Environmental Health Part B Critical Reviews. 2007. 10: 235-257. https://doi.org/10.1080/15287390600974924
- Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO Journal. 1998. 17: 2596-2606. https://doi.org/10.1093/emboj/17.9.2596
- Sauer H, Wartenberg M, Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cellular Physiology and Biochemistry. 2001. 11: 173-186. https://doi.org/10.1159/000047804
-
Seo HS, Choi HS, Kim SR, Choi YK, Woo SM, Shin I, Woo JK, Park SY, Shin YC, Ko SG. Apigenin induces apoptosis via extrinsic pathway, inducing p53 and inhibiting STAT3 and
$NF{\kappa}B$ signaling in HER2-overexpressing breast cancer cells. Molecular Cellular Biochemistry. 2012. 366: 319-334. https://doi.org/10.1007/s11010-012-1310-2 - Singh NN, Ramji DP. Protein kinase CK2, an important regulator of the inflammatory response? Journal of Molecular Medicine (Berl). 2008. 86: 887-897. https://doi.org/10.1007/s00109-008-0352-0
- Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987. 235: 177-182. https://doi.org/10.1126/science.3798106
- Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S, Demeter J, Perou CM, Lnning PE, Brown PO, Brresen-Dale AL, Botstein D. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proceedings of the National Academy of Sciences of the USA. 2003. 100: 8418-8423. https://doi.org/10.1073/pnas.0932692100
-
Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of
$H_2O_2$ for platelet-derived growth factor signal transduction. Science. 1995. 270: 296-299. https://doi.org/10.1126/science.270.5234.296 -
Thannickal VJ, Fanburg BL. Activation of an
$H_2O_2$ -generating NADH oxidase in human lung fibroblasts by transforming growth factor beta 1. Journal of Biological Chemistry. 1995. 270: 30334-30338. https://doi.org/10.1074/jbc.270.51.30334 - Toikkanen S, Helin H, Isola J, Joensuu H. Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-tear follow-up. Journal of Clinical Oncology. 1992. 10: 1044-1048. https://doi.org/10.1200/JCO.1992.10.7.1044
- Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annual Review of Pharmacology and Toxicology. 1996. 36: 203-232. https://doi.org/10.1146/annurev.pa.36.040196.001223
- Zhang J, Shen B, Lin A. Novel strategies for inhibition of the p38 MAPK pathway. Trends Pharmacological Sciences. 2007. 28: 286-295. https://doi.org/10.1016/j.tips.2007.04.008